Product NDC: | 0942-9005 |
Proprietary Name: | ACD-A |
Non Proprietary Name: | Antiocoagulant Citrate Dextrose Solution, Formula A |
Active Ingredient(s): | 730; 2.45; 2.2 mg/100mL; g/100mL; g/100mL & nbsp; Antiocoagulant Citrate Dextrose Solution, Formula A |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0942-9005 |
Labeler Name: | Fenwal Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BN160918 |
Marketing Category: | NDA |
Start Marketing Date: | 20121024 |
Package NDC: | 0942-9005-01 |
Package Description: | 1000 mL in 1 BAG (0942-9005-01) |
NDC Code | 0942-9005-01 |
Proprietary Name | ACD-A |
Package Description | 1000 mL in 1 BAG (0942-9005-01) |
Product NDC | 0942-9005 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Antiocoagulant Citrate Dextrose Solution, Formula A |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20121024 |
Marketing Category Name | NDA |
Labeler Name | Fenwal Inc. |
Substance Name | ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM CITRATE |
Strength Number | 730; 2.45; 2.2 |
Strength Unit | mg/100mL; g/100mL; g/100mL |
Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |